Congressionally Directed Medical Research Programs (CDMRP) -- Peer Reviewed Cancer Research Program (PRCRP) -- Impact Award

Funding Agency:
Department of Defense

The FY23 PRCRP Impact Award supports hypothesis-driven, high-impact research. The intent of the Impact Award mechanism is to fund mature research projects that specifically focus on critical scientific or clinical cancer issues, which have the potential to make a major near-term impact on at least one of the FY23 PRCRP Topic Areas. Important factors under consideration will be continuity of research, clinical applicability, and leveraging of clinical samples and trials. The Impact Award supports identifying scientific outcomes that, through rigorous, robust research, are translatable toward treatment and/or preventive strategies. Research proposed should aim to accelerate promising findings toward clinical applicability and leverage research results to maximize impact.


  • Required Pre-Application Submission Deadline: ¬†May 25, 2023
  • Invitation to Submit an Application: June 29, 2023
  • Application Submission Deadline:¬†September 12, 2023

Agency Website

Areas of Interest

To be considered for funding, applications for the FY22 PRCRP Impact Award must address at least one of the congressionally directed FY22 PRCRP Topic Areas. Congressional language stipulates the FY22 PRCRP must not fund research into breast, kidney, lung, pancreatic, prostate, ovarian, rare cancer, and melanoma. Applicants are directed to apply to the individual CDMRP cancer programs covering those disease areas. Research applications in the areas of breast, kidney, lung, pancreatic, prostate, ovarian, rare cancer, or melanoma are prohibited and will be rejected. The inclusion of the individual Rare Cancers Research Program shall not prohibit the funding of the FY22 PRCRP congressionally directed cancers or cancer subtypes that may be rare by definition.

Eligibility Requirements

Independent investigators at or above the level of Assistant Professor (or equivalent) are eligible to be named as the PI on the application. An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization.



Amount Description

The anticipated direct costs budgeted for the entire period of performance for an FY23 PRCRP Impact Award should not exceed $1.0M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.

Funding Type



Junior Faculty


Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 25, 2023